UDMIN
MRP: 240
Packaging: 10 ML
Pack Type: injection
Composition:
L-Ornithine-L-Aspartate 5g. 10ml Inj.
Indication:
Jaundice, Chronic Alcoholism, Fatty Liver Disease, Prolonged Illness, As Supportive Therapy
Description:
L-Ornithine L-Aspartate (LOLA) 5g Injection is a liver detoxification agent used primarily in the treatment of hepatic encephalopathy, liver cirrhosis, and elevated ammonia levels (hyperammonemia). This injectable formulation rapidly reduces blood ammonia levels and improves liver function by enhancing the urea cycle and glutamine synthesis.
Each 10ml ampoule contains 5g of L-Ornithine L-Aspartate, administered intravenously for quick action. It is especially beneficial in acute liver conditions, chronic hepatic failure, or post-operative liver support.
Tags:
- Reduces elevated ammonia levels in the blood
- Enhances liver detoxification
- Improves mental clarity in hepatic encephalopathy
- Supports liver function in cirrhosis and failure
- Fast-acting intravenous liver therapy
Usage Information
Dosage
Route: Intravenous (IV) infusion Typical Dose: 1–2 ampoules (5–10g) diluted in 250–500ml saline or glucose solution Frequency: Once or twice daily, depending on the severity of the condition Should be administered under medical supervision
Side Effects
Nausea Vomiting Mild abdominal discomfort Allergic reaction (rare) Electrolyte imbalance with prolonged use
Contraindications
Severe renal impairment Known hypersensitivity to L-Ornithine or L-Aspartate Patients with hereditary fructose intolerance (if mixed with fructose-containing solutions) Use with caution in pregnant or lactating women
Availability
L-Ornithine L-Aspartate injection 5g LOLA 5g/10ml injection for liver support Injection for hepatic encephalopathy Ammonia-lowering liver detox injection IV liver detoxifier